Akebia Therapeutics News, Akebia Therapeutics Quote, AKBA Quote

Akebia Therapeutics (NQ:AKBA) Delayed: 1.32 -0.05 (3.65%)

Prev. Close

$1.37

Open

$1.35

52 Wk High

$13.20

52 Wk Low

$7.00

Day High

$1.35

Day Low

$1.31

P/E

N/A

EPS

$0.00

Volume

673,968

Apr 23, 2024 08:33 AM Form 8-K Akebia Therapeutics, For: Apr 17
Apr 16, 2024 07:34 AM Form 8-K Akebia Therapeutics, For: Apr 15
Apr 2, 2024 04:05 PM Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 1, 2024 06:53 AM Akebia Therapeutics (AKBA) PT Raised to $6 at H.C. Wainwright, 'favorable label to daprodustat'
Mar 28, 2024 06:10 AM Form 8-K Akebia Therapeutics, For: Mar 27
Mar 27, 2024 08:56 PM Akebia Therapeutics (AKBA) Receives FDA Approval for Vafseo Tablets
Mar 27, 2024 08:32 PM Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Mar 15, 2024 04:09 PM Akebia Therapeutics (AKBA) Announces CFO Transition
Mar 15, 2024 04:08 PM Form 8-K Akebia Therapeutics, For: Mar 15
Mar 14, 2024 05:20 PM Form 10-K Akebia Therapeutics, For: Dec 31

Entities mentioned with AKBA